(Q37206243)

18 August 2017

1 reference

title

Caveolin-1: a marker for pancreatic cancer diagnosis (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

Cristiana Pistol Tanase

series ordinal

1

1 reference

18 August 2017

1 July 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

4

1 reference

18 August 2017

395-404

1 reference

18 August 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Molecular prognostic factors in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 expression in benign and malignant lesions of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolae/caveolin-1 are important modulators of store-operated calcium entry in Hs578/T breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Therapeutic targets for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Role of caveolae and caveolins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 in oncogenic transformation, cancer, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1: a tumor-promoting role in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Multiple functions of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Distinction between signaling mechanisms in lipid rafts vs. caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

The Ras-MAPK pathway downregulates Caveolin-1 in rodent fibroblast but not in human fibroblasts: implications in the resistance to oncogene-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 as a potential new therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

The expression of rho proteins decreases with human brain tumor progression: potential tumor markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Differential expression and function of caveolin-1 in human gastric cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

The cyclin D1 gene is transcriptionally repressed by caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Hypermethylation of the caveolin-1 gene promoter in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TY

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Expression of caveolin-1 in gastrointestinal and extraintestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

Differential expression of caveolin-1 in renal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.395

21 January 2018

Identifiers

DOI

10.1586/14737159.8.4.395

1 reference

18 August 2017

1 reference

PubMed ID

18598222